Filing Flows

Filing Flows › Industrials › Syra Health (SYRA)

Syra Health (SYRA) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 3, 2026 · Syra Health (SYRA) Q3 2026 earnings results →

Q3 2026 Revenue up 52% year over year to $2.6M · 13¢ of every $1 of revenue kept as net profit · operating margin 11.7%

Syra Health made $2.6M in Q3 2026 (+52% Y/Y): Population Health $1.9M, Healthcare Workforce $614K. Operating margin 11.7%, net earnings $345K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 3, 2026.

Revenue$2.6M
Year over year+52%
Operating margin11.7%
Net earnings$345K
Operating cash flow$332K

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $2.6M in Q3 2026, up 52% year over year and up 7% from the previous quarter. Population Health was the largest line at 76% of revenue. Population Health added $664K year over year (up 52%), 76% of the total change.

Gross margin was 46.3%, up 13.5 points from Q3 2025. Operating profit was $300K, a 11.7% margin (up 25.5 points year over year). Operating expenses grew 12% against revenue growth of 52%. The fastest-growing cost line was Research & development (+5625%). Net earnings were $345K. The effective tax rate was -15.0%.

Operating cash flow was $332K, 96% of net earnings. Non-cash charges added back $1K of depreciation and $45K of share-based compensation. Working capital and other items used $59K.

Quarterly history

Syra Health revenue by quarterSyra Health revenue by quarter$1.9MQ1 2025$1.9MQ2 2025$1.7MQ3 2025$1.7MQ4 2025$2.3MQ1 2026$2.4MQ2 2026$2.6MQ3 2026
Syra Health net earnings by quarterSyra Health net earnings by quarter−$472KQ1 2025−$64KQ2 2025−$226KQ3 2025−$135KQ4 2025$241KQ1 2026$250KQ2 2026$345KQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 3, 2026$2.6M+52%11.7%$345K$332K
Q2 202610-QAug 11, 2026$2.4M+23%10.5%$250K−$719K
Q1 202610-QMay 7, 2026$2.3M+22%8.4%$241K$1.4M
Q4 202510-KMar 12, 2026$1.7M-14%-7.8%−$135K−$289K
Q3 202510-QNov 12, 2025$1.7M-25%-13.8%−$226K−$244K
Q2 202510-QAug 12, 2025$1.9M-1%-3.2%−$64K−$72K
Q1 202510-QMay 8, 2025$1.9M+6%-25.5%−$472K$158K

Charts

Syra Health: revenue growth, year over year and quarter over quarterSyra Health: revenue growth, year over year and quarter over quarterY/YQ/Q+6%Q1 2025-1%+5%Q2 2025-25%-13%Q3 2025-14%+3%Q4 2025+22%+31%Q1 2026+23%+5%Q2 2026+52%+7%Q3 2026
Latest (Q3 2026): Y/Y +52%, Q/Q +7%.
Syra Health: where the cash came from (+) and went (−), TTM to Q3 2026Syra Health: where the cash came from (+) and went (−), TTM to Q3 2026Operating cash flow$686KCash drawn (+) / kept (−)−$407KNet borrowing (+) / repaid (−)−$279KNot reconciled−$107
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Syra Health: profit against cash, quarter by quarterSyra Health: profit against cash, quarter by quarterNet incomeOperating cash flow−$504K−$215KQ4 2024−$472K$158KQ1 2025−$64K−$72KQ2 2025−$226K−$244KQ3 2025−$135K−$289KQ4 2025$241K$1.4MQ1 2026$250K−$719KQ2 2026$345K$332KQ3 2026
Latest (Q3 2026): Net income $345K, Operating cash flow $332K.
Syra Health: diluted shares by fiscal yearSyra Health: diluted shares by fiscal year3MFY20225MFY20238MFY202412MFY2025
+289.7% since FY2022: more shares outstanding (issuance, stock pay).

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

Customers and suppliers named in filings

Sells to

About Syra Health

Syra Health is an integrated healthcare solutions company serving government and commercial healthcare organizations with prevention-focused, accessible, and affordable solutions that improve health outcomes. We deliver end-to-end capabilities across population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. Mental health concerns are rapidly growing on a global scale, yet the shortage of mental health professionals and access to treatment is leaving millions of people without access to mental health resources. We strongly believe in behavioral and mental health equity and our mission is to provide solutions that help improve health care and provide access to all populations, regardless of race, ethnicity, gender, socioeconomic status, sexual orientation, or geographic location.

In its own words, from its 10-K, filed Mar 12, 2026.

Syra Health against its Services-Employment Agencies peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +52% against the peers' median +7%. Operating margin: 11.7% against the peers' median 11.7%.

CompanyQuarterRevenueY/YOp. margin
SYRA Syra HealthQ3 2026$2.6M+52%11.7%
KFY Korn FerryQ1 FY27$765M+7%12.2%
JOB GEE GroupQ3 FY26$20.8M-15%1.8%

Source: Syra Health 10-Q on SEC EDGAR · CIK 1922335 · Services-Employment Agencies

Guidance and outlook

Syra Health: what its forward-looking statements are about (10-Q filed 2026-11-03)Syra Health: what its forward-looking statements are about (10-Q filed 2026-11-03)Demand6Other6Legal & regulation2Costs1Margins1Financing1
17 statements; tone +0.35 (−1 all cautious, +1 all confident); 3 hedged.
Syra Health: outlook statements against the filing beforeSyra Health: outlook statements against the filing beforeConfident6

13F: who owns SYRA and who is buying

Funds' net buying of SYRA by quarter (13F)Funds' net buying of SYRA by quarter (13F)$198K2024-09−$45K2024-12−$101K2025-03$4222025-06$02025-09
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on SYRA

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare SYRA with

中文版:Syra Health(SYRA)财报

Español · Français